Overview

Arnuity Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Arnuity Ellipta is not indicated for rescue usage during acute bronchospasms. Arnuity Ellipta is also known by its drug name, Fluticasone furoate.

Arnuity Ellipta should be used with caution in pregnant women and people with glaucoma, liver disease or high risk for osteoporosis. Arnuity Ellipta should not be used by people who are experiencing an acute bronchospasm or as primary treatment for those with status asthmaticus. Arnuity Ellipta is not suitable for use in people who have prev... read more

Arnuity Ellipta (Fluticasone furoate) Questions

MyCOPDTeam is a free social network that makes it easy to find others like you and gain insights from others living with COPD.
Sign up Log in